COMMUNIQUÉS West-GlobeNewswire

Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update
13/08/2025
–Completed enrollment in Phase 3 ONWARD clinical trials for envudeucitinib in moderate-to-severe plaque psoriasis; topline readout expected in early Q1 2026– –Completed enrollment in Phase 2b LUMUS clinical trial for [...]
Glass House Brands Reports Second Quarter 2025 Financial Results
13/08/2025
Results surpassed expectations across key metrics including biomass production, revenue, gross profit, and Adjusted EBITDA Wholesale biomass production was 230,748 pounds, up 54% year-over-year Cost of production was $ [...]
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
13/08/2025
Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs, supporting potential for improved protection against infection Enrolled approximately [...]
Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
13/08/2025
Completed Strategic Leadership and Operational Transformation from R&D to Commercial Operations Rebranded as Dyadic Applied BioSolutions to Reflect Our New Operational Priorities Full Redesign of Corporate Website [...]
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
13/08/2025
ROCKVILLE, MD, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based therapeutics for the treatment of cancer, today [...]
Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results
13/08/2025
Successfully establishes cryptocurrency treasury reserve focused on the HYPE token and becomes the first publicly listed U.S. company to implement DeFi strategies on Hyperliquid blockchain Accumulates more than 1.5 [...]
Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
13/08/2025
Tevogen.AI to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating [...]
Building Muscle After 50: Why CrazyBulk Muscle Growth & Strength Supplements for Over 50's are Best Sellers in 2025
13/08/2025
New York City, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- In 2025, CrazyBulk is redefining building muscle after 50 by boosting healthy testosterone levels, improving mTOR responsiveness, and enhancing recovery - so men 50+ [...]

Pages